Dovetail Genomics
Genomic research with cutting-edge proximity ligation technology for unprecedented access to genetic variation and 3D regulatory landscapes.
| Date | Investors | Amount | Round |
|---|---|---|---|
* | $2.0m | Grant | |
| Total Funding | 000k | ||
Related Content
Dovetail Genomics is at the forefront of genomic research, offering innovative solutions that unlock the full potential of genetic information. The company's proprietary proximity ligation technology enables researchers to gain unprecedented insights into genetic variation, variant phasing, and the three-dimensional regulatory landscape of any genome.
By providing both cutting-edge kits and comprehensive services, Dovetail Genomics empowers scientists to maximize the information generated from every sequencing run. Their product portfolio includes solutions for epigenetics, genetic variation analysis, and high-quality genome assembly, catering to a wide range of applications in academic research, pharmaceutical development, and biotechnology.
The company's technology has far-reaching implications for various fields, including drug discovery, personalized medicine, and biodiversity research. By facilitating a deeper understanding of genomic structures and regulatory networks, Dovetail Genomics is helping to accelerate scientific discoveries and drive innovation in the life sciences sector.